About peptomyc_2015

This author has not yet filled in any details.
So far peptomyc_2015 has created 39 blog entries.

Peptomyc wins Startup Slam competition at BIO-Europe Spring® Barcelona

25 / 03 / 17|

Neruda Scott (Johnson & Johnson), Bauke Anninga (Innovation Forum), Laura Soucek (Peptomyc) and Emma Kohring (Johnson & Johnson).


Panel of expert judges selects winner from 14 short-listed European start-ups that showed greatest potential for transformative healthcare solutions

Startup Slam sponsor and co-host Johnson & Johnson Innovation recognizes high caliber of entries selected to compete for prestigious award


Peptomyc is proud to join CatalonioBio

24 / 03 / 17|

Peptomyc receives 850K € from Spanish Mineco and European Commission joint fund

30 / 11 / 16|

Peptomyc wins prize at EIT Health Summit

23 / 11 / 16|

Peptomyc completed a successful and constructive Briefing Meeting with the Innovation Task Force of the European Medicines Agency (EMA) at their headquarters in London, U.K.

19 / 09 / 16|

Peptomyc completes Seed Funding of €1M

27 / 04 / 16|

Funds will help company reach preclinical validation for lead candidate in glioblastoma – an aggressive and lethal brain tumor – and in other cancer indications.


Peptomyc receives a business grant from ACCIÓ

22 / 03 / 16|


This second grant in 2 months further supports Peptomyc in its mission to bring novel Myc inhibitors closer to clinical use for cancer treatment.


Peptomyc succeeds in gaining first grant funding from the European Commission

22 / 02 / 16|


This grant represents the first big step forward for the company as it looks for further funding from investors to bring its novel Myc inhibitors closer to clinical application in cancer.


VHIR´s Health Innovation Contest 2015: first place goes to Myc Inhibitory Peptide

17 / 07 / 15|

Source: The Vall d´Hebron Institute of Oncology